Top Stories
Consumer health giant Haleon sees higher revenue in 2024
Global Banking & Finance Review®
Company
(Reuters) – Sensodyne toothpaste-maker Haleon said on Thursday it expected higher revenue in 2024, thanks to firm demand for its household products ranging from painkillers, nasal sprays and multivitamins.
(Reuters) – Sensodyne toothpaste-maker Haleon said on Thursday it expected higher revenue in 2024, thanks to firm demand for its household products ranging from painkillers, nasal sprays and multivitamins.
Haleon said its organic revenue would rise between 4%-6% this year, as the consumer healthcare company reported its first full-year results since it was spun off from GSK in 2022.
Analysts on average expect organic revenue to grow by 4.5%, according to a company-compiled consensus.
(Reporting by Eva Mathews in Bengaluru; Editing by Subhranshu Sahu)
Organic revenue refers to the income generated from a company's existing operations, excluding any income from acquisitions or mergers. It reflects the company's growth from its core business activities.
A financial analyst evaluates financial data to help businesses make informed investment decisions. They analyze trends, prepare reports, and provide recommendations based on their findings.
Explore more articles in the Top Stories category
